baber/WOPTO huggingface dataset:
Patent EP-0505469-B2 (EP)
Inventor: KLIER KONRAD
IPC: B05D7/24
Filed: 1990-12-19
Granted: 1996-05-15
Abstract: PCT No. PCT/EP90/02256 Sec. 371 Date Jul. 21, 1992 Sec. 102(e) Date Jul. 21, 1992 PCT Filed Dec. 12, 1990 PCT Pub. No. WO91/09686 PCT Pub. Date Jul. 11, 1991.The present invention relates to a process in which 1. a water-dilutable basecoat composition is applied which contains at least one water-dilutable binder, metallic pigments, if desired color pigments, if desired conventional auxiliaries and additives and up to 20% by weight of organic solvents, 2. a polymer film is formed from this basecoat composition, 3. a transparent topcoat containing a polymer containing silyl groups and obtainable by copolymerization of p1 p1) 0.1 to 40% by weight of ethylenically unsaturated silane monomers of the general formula  (* CHEMICAL STRUCTURE *)   where R1 is alkyl, aryl, acyl, aralkyl having 1 to 10 carbon atoms R2 is an organic radical having a polymerizable double bond X is a hydrolyzable group n is 1, 2 or 3 p2) 5 to 30 % by weight, preferably 8 to 25% by weight, of monomers having at least 2 polymerizable ethylenically unsaturated double bonds and p3) 30 to 90% by weight of ethylenically unsaturated monomers without groups having active hydrogen, is applied to this base layer 4. and the top layer is cured together with the base layer.
Patent EP-0654062-B2 (EP)
Inventor: LAMBERTS WILHELM
IPC: B65D90/00
Filed: 1993-07-22
Granted: 2001-01-17
Abstract: PCT No. PCT/EP93/01957 Sec. 371 Date Jan. 27, 1995 Sec. 102(e) Date Jan. 27, 1995 PCT Filed Jul. 22, 1993 PCT Pub. No. WO94/03532 PCT Pub. Date Feb. 17, 1994The present invention relates to hard polyurethane foams. These foams are produced by the reaction of 1) polyisocyanates, with 2) compounds having molecular weights of from 92 to 10,000 and having at least two hydrogen atoms which are reactive with isocyanate groups, in the presence of 3) hydrofluoroalkanes as foaming agents, and 4) solubilizers. Suitable solubilizers comprise one or more of   R1OCOOR2; a) R2OCOOCOOR2; or   <IMAGE>   wherein R1 and R2 signify C1-C12-alkyl or together C2-C6-alkylene and n signifies an integer from 0 to 6;lkyl which is optionally substituted by halogens, C5-C10-cycloalkyl or optionally substituted aryl; lkyl or C5-C10-cycloalkyl; and/or    <IMAGE>  d)  wherein R signifies C1-C20 alkyl or C5-C10 cycloalkyl.
Patent EP-0679187-B2 (EP)
Inventor: SCHAWALLER MANFRED
IPC: G01N33/68
Filed: 1994-01-12
Granted: 2001-07-04
Abstract: PCT No. PCT/DE94/00022 Sec. 371 Date Sep. 29, 1995 Sec. 102(e) Date Sep. 29, 1995 PCT Filed Jan. 12, 1994 PCT Pub. No. WO94/16081 PCT Pub. Date Jul. 21, 1994The present invention is relative to a method for the obtention of native domains of viral membrane proteins, especially of native, that is, oligomeric and glycosylated ectodomains of the surface protein gp160 of the human immunodeficiency virus HIV, the causative agent of AIDS (acquired immune deficiency syndrome), as well as the native protein domains themselves obtained by this method, especially native ectodomains of the env glycoprotein of HIV whose monomers exhibit an electrophoretic mobility of approximately 140 kD as well as their use as vaccine, especially as vaccine against HIV. A nucleotide sequence coding for a recognition sequence for protein-splitting enzymes is inserted at a suitable site into the gene coding for the precursor protein of the protein domain to be obtained. After expression of the gene mutant in eukaryotic cells a digestion with a suitable enzyme is carried out and the protein domain to be obtained is subsequently purified.
Patent EP-0792468-B2 (EP)
Inventor: VAN GEMERT BARRY
IPC: C07D311/96
Filed: 1995-11-03
Granted: 2005-05-04
Abstract: Described are novel photochromic indeno-fused naphthopyran compounds, examples of which are naphthopyran compounds having a substituted or unsubstituted indeno group, the 2,1 positions of which are fused to the f side of the naphtho portion of the naphthopyran, and certain substituents at the 3-position of the pyran ring. Certain substituents may also be present at the number 5, 6, 7, 8, 9, 10, 11, 12, or 13 carbon atoms of the compounds. These compounds may be represented by graphic formula (I). Also described are polymeric organic host materials that contain or that are coated with such compounds. Optically clear articles such as ophthalmic lenses or other plastic transparencies that incorporate the novel naphthopyran compounds or combinations thereof with complementary photochromic compounds, e.g., certain other naphthopyrans, benzopyrans, and spiro(indoline)type compounds, are also described.
Patent JP-2675614-B2 (JP)
IPC: C07H3/04
Filed: 1989-04-25
Granted: 1997-11-12
Abstract: The invention relates to a new method of preparing lactulose by basic isomerisation of lactose. According to the invention the reaction mixture is treated with hydrogen peroxide or sodium chlorite to obtain lactulose of an acceptable colour for a pharmaceutical product. Preferably 0.5 - 5 g of hydrogen peroxide are used per kg of lactose. 1H2O.
Patent JP-H0362685-B2 (JP)
IPC: A61K8/00
Filed: 1985-05-17
Abstract: PURPOSE:A granular cosmetic, obtained by incorporating L-ascorbic acid or a derivative thereof with a surfactant, capable of readily collapsing the granules, readily compatible with water and rapidly dispersible without roughness on application to the skin. CONSTITUTION:A granular cosmetic obtained by incorporating one or two or more selected from the group consisting of L-ascorbic acid (odorless white crystal powder having an acid taste) widely present in natural plants, e.g. lemon, orange or fresh vegetables, and a derivative thereof, e.g. L-ascorbyl stearate, L-ascorbyl palmitate, L-ascorbic acid phosphate magnesium salt or L-ascorbic acid sodium sulfate (preferably 5-20wt% based on the total amount) with a surfactant, e.g. POE (20) sorbitan monolaurate or POE (15) glyceryl monooleate (preferably in an amount of 1/40-1/10 times based on the L-ascorbic acid).
Patent JP-2749951-B2 (JP)
IPC: C07D295/08
Filed: 1990-04-27
Granted: 1998-05-13
Abstract: A triphenylmethane derivative represented by the following general formula: <CHEM> exhibits born absorption inhibiting effects and is useful as a medicament for treating osteoporosis.
Patent JP-2575350-B2 (JP)
IPC: C11D7/54
Filed: 1985-06-21
Granted: 1997-01-22
Abstract: Per-acids and per-acid precursor compounds of the general type RXAOOH and RXAL, wherein R is a hydrocarbyl group, X is a hetero-atom, A is a carbonyl bridging group and L is a leaving group, especially oxybenzenesulfonate, are useful bleaching compounds for fabrics. Laundry products containing same are disclosed.
Patent JP-S6410230-B2 (JP)
IPC: A61M1/00
Filed: 1984-07-06
Abstract: Process/apparatus for the processing of body fluids, advantageously comprising plasmapheresis technique for the fractionation of whole blood, features (i) means, e.g., a common blood transfusion needle, for withdrawing and returning body fluid from and to a living patient; (ii) a body fluid separating module which comprises an upstream first compartment and a downstram second compartment, and having a semi-permeable membrane body fluid separator disposed therebetween; (iii) first conduit means communicating said withdrawal and return means (i) with the upstream first compartment of said separating module (ii); (iv) means provided along said first conduit (iii) for conveying body fluid in either direction therein; (v) means responsive to said conveying means (iv), adapted to monitor the pressure of body fluid circulating in said first conduit (iii), and provided between said withdrawal and return means (i) and said conveying means (iv); (vi) means for collecting body fluid transported across said semi-permeable membrane and communicating with the downstream second compartment of said separating module (ii); (vii) second conduit means communicating the upstream first compartment of said module (ii) to (viii) means for containing body fluid which has not been transported across said semi-permeable membrane thereof, (ix) third conduit means communicating said container means (viii) to said first conduit means (iii) at a point intermediate said conveying means (iv) and the upstream first compartment of said separating module (ii); (x) means provided along said first conduit (iii) at a point intermediate the upstream first compartment of said separating module (ii) and the juncture of communication between said container means (viii) and the said first conduit means (iii), for conveying body fluid therein in the direction of the said upstream first compartment; and (xi) means for ensuring that the pressure across the said semi-permeable membrane of any body fluid in contact therewith does not exceed predetermined value.
Patent JP-S6254900-B2 (JP)
IPC: D04B7/00
Filed: 1979-11-06
Abstract: The present invention provides a method of and mechanism for transferring a knitted fabric from the knitting needles (28) of a flat knitting machine (10) to the needles (38) of a magazine bar (21).One of the beds (12) of the machine is dropped slightly and the tips of transfer elements (24) are brought into juxtaposition with the needles (28). The tips of the elements (24) are then engaged in the eyes of the needles (28) which are then withdrawn to transfer the loops of the fabric to the elements (24). The latter are then moved into engagement with the needles (38) of the magazine bar (21) and the loops transferred to the magazine needles by means of teeth (52) of a member (50) which engage and carry the loops from the elements (24) to the needles (38).
Patent JP-H0649862-B2 (JP)
IPC: C09K23/52
Filed: 1989-06-08
Abstract: A liquid system includes a liquid medium and a thickening mixture, the thickening mixture being dispersed in the liquid medium and comprising a synergistic mixture of a gum-type polymer and an acrylic-type polymer. The thickening system is applicable to a wide variety of systems, including detergent and cleaning compositions.
Patent JP-3951504-B2 (JP)
IPC: H05B37/02
Filed: 1999-05-31
Granted: 2007-08-01
Abstract: PROBLEM TO BE SOLVED: To provide a lighting system capable of correcting the initial illuminance corresponding to a space (a store, for example), etc., for varying light modulating levels in accordance with differences of reflectivity of a floor or time (time instant), etc., and of reducing a device in size. SOLUTION: This lighting system is constituted of a plurality of luminaires 4, a light modulation signal output part 3 for outputting the light modulation signal for controlling the light output of the plurality of luminaires 4, and a data correction operating part 2 for correcting the light modulation signal outputted from the light modulation signal output part 3. The data correction operating part 2 operates the data correction according to a luminous flux decreasing characteristic correction light modulation data table 1, a lighting hour timer 6, a clock 5 and a reflectivity correction table 7. A reflectivity selecting switch 8 selects the reflectivity of the space to be used or a radiated surface.
Patent JP-H0689102-B2 (JP)
IPC: C08J9/00
Filed: 1987-06-19
Abstract: Rigid polyurethane foams are obtained by reacting an isocyanate-reactive component containing at least two isocyanate-reactive hydrogen atoms, having a molecular weight of from 32 to 10.000 or a mixture thereof, with a polyisocyanate composition comprising   (a) 30 to 70 pbw of polymethylene polyphenyl polyisocyanate with an isocyanate content of from 29 to 32%, (b) 30 to 70 pbw of a compound having 30 to 42% by weight isocyanate content obtained by reacting 2,4- and/or 2,6-tolylene diisocyanate with an active hydrogen containing compound, thereafter initiating a reaction in the presence of trimerization catalyst, if necessary diluted with 2,4- and/or 2,6-tolylene diisocyanate, (c) 0 to 30 pbw of other isocyanate compounds in the presence of water and/or organic blowing agents, catalysts and surfactants. e
Patent JP-S6147517-B2 (JP)
IPC: C12P17/04
Filed: 1979-12-07
Abstract: A process for the preparation of a 15  alpha -hydroxyprostaglandin intermediate of the formula    <IMAGE>  I,  wherein R1 is phenoxymethyl, phenoxymethyl substituted on the phenyl moiety by halogen or trifluoromethyl, or alkyl of 1-5 carbon atoms, and R2 is hydrogen, acetyl, benzoyl or p-phenylbenzoyl, which comprises stereospecifically microbiologically reducing a corresponding 15-ketone of the formula    <IMAGE> II,  with a strain of the microorganism Kloeckera, Saccharomyces or Hansenula.
Patent JP-S6233879-B2 (JP)
IPC: C12N7/02
Filed: 1984-08-09
Abstract: Disclosed is an improved method for the purification of Japanese encephalitis virus, which comprises subjecting a solution containing the Japanese encephalitis virus to column chromatography using, as a gel for chromatography, a sulfuric acid ester of cellulose or a crosslinked polysaccharide. The method can provide highly purified Japanese encephalitis virus, which is useful for obtaining an effective vaccine against Japanese encephalitis.
Patent JP-2803678-B2 (JP)
IPC: H01L21/683
Filed: 1989-08-18
Granted: 1998-09-24
Abstract: An oxide film having a thickness of several tens to a hundred angstroms is formed on a metal surface or at least on its portion that comes in contact with an electrically material, the oxide film being formed in a highly pure oxidising atmosphere. By using this contact member, the wafer potential can be maintained to be lowe than 50 V at all times yet completely preventing the wafers from being contaminated (particularly, with metal).@(17pp dwg.No.4/4)@.
Patent JP-2633361-B2 (JP)
IPC: C11D17/00
Filed: 1989-08-28
Granted: 1997-07-23
Abstract: The invention relates to syndet soap cakes (soap bars) containing, in addition to the usual components, from about 0.001 to about 10% by weight of perfluoropolyethers having perfluoroalkyl end groups. Among the suitable perfluoropolyethers are those which contain one or more perfluorooxyalkylene units selected from (CF2-CF2O), (CF2O), (C3F6O), (CF2O-CF2-CF2O), (CF2-CF2-CF2O), <CHEM>  and <CHEM> wherein the groups RfIII are fluorine atoms or perfluoroalkyl groups.
Patent JP-2810034-B2 (JP)
IPC: C07D307/33
Filed: 1997-08-25
Granted: 1998-10-15
Abstract: The present invention provides a process for preparing lactone intermediates to 2',2'-difluoronucleosides whereby reversion back to the lactone's open chain precursor is minimized and the desired erythro enantiomer can be selectively isolated from an enantiomeric mixture of erythro and threo lactones in crystalline form. Also provided is a process for producing 2'-deoxy-2',2'-difluoronucleosides in about a 1:1 α/β anomeric ratio, and processes for selectively isolating β-2'-deoxy-2',2'-difluorocytidine, or an organic or inorganic acid addition salt thereof, from the 1:1 α/β mixture.
Patent JP-3727692-B2 (JP)
IPC: C12Q1/6806
Filed: 1995-09-12
Granted: 2005-12-14
Abstract: Nucleic acids can be made available for amplification or other treatment after lysis by contacting the lysate with polyethyleneimine to form a precipitate with the nucleic acids. The nucleic acids are then released from the precipitate by contact with a strong base, and the released nucleic acids are kept in solution with an anionic phosphate ester surfactant. This method for preparing specimen samples is simple and quite rapid. <IMAGE>
Patent JP-H0212958-B2 (JP)
IPC: C07H15/22
Filed: 1986-10-09
Abstract: A novel process for the synthesis of amikacin starting from kanamycin A protected at the positions 3 and 6' is described comprising the reaction of the latter with a salt of a bivalent metal cation selected among zinc, nickel, iron, cobalt, manganese, copper and cadmium in the presence of water as the solvent or co-solvent followed by the in situ reaction of the resulting complex with a reactive derivative of L-amino-2-hydroxybutyric acid, removal of the metal cation of the protecting groups and purification of the thus obtained raw product. the acylation under these conditions is extremely selective.
Patent JP-2757960-B2 (JP)
IPC: C07C229/48
Filed: 1988-10-17
Granted: 1998-05-25
Abstract: (2R,3S,4S)- alpha -(carboxycyclopropyl)glycine of the formula (1) and salts thereof are disclosed. <CHEM> The compound (1) exhibits most potent depolarizing activities among the known NMDA agonists and will be a useful tool to investigate various neuronal functions related to the excitatory amino acid receptors.
Patent JP-2922122-B2 (JP)
IPC: C07D215/42
Filed: 1994-10-26
Granted: 1999-07-19
Abstract: The invention relates to aminoquinoline derivatives of the general formula <IMAGE>     in which the symbols R<1> to R<6> are hydrogen or one or two thereof are alkyl and the others are hydrogen, R<7> and R<8> are alkyl, alkenyl, aralkyl or, together with N, pyrrolidine or piperidine, also substituted by alkyl, octahydroindole or 3-azabicyclo[3.2.2]nonane and n = 0 or 1 or in which the symbols R<1> and R<3> are tri- or tetramethylene, all the other substituents up to R<6> are hydrogen, n = 0 and R<7> and R<8> have the above meanings, or in which the symbols R<1> and R<7> are methylene or dimethylene and n = 1,   R<1> and R<7> are di- or trimethylene and n = 0,   R<3> and R<7> are di- or trimethylene and n = 1,   R<3> and R<7> are tri- or tetramethylene and n = 0,   R<5> and R<7> are tri- or tetramethylene and n = 1, R<1> and R<5> are di- or trimethylene and n = 1, all the other substituents are hydrogen apart from R<8>, which is alkyl, alkenyl or aralkyl, or in which the symbols R<3> and R<5> are tri- or tetramethylene and n = 1, all the other substituents up to R<6> are hydrogen and R<7> and R<8> are alkyl, alkenyl, aralkyl or, together with N, pyrrolidine or piperidine, also substituted by alkyl, R<9> is hydrogen or halogen and R<10> is halogen or trifluoromethyl, and pharmaceutically acceptable salts of basic compounds of the general formula I for producing pharmaceuticals for controlling both chloroquine-resistant and chloroquine-sensitive malaria pathogens.
Patent JP-2650924-B2 (JP)
IPC: H01J29/88
Filed: 1987-10-26
Granted: 1997-09-10
Abstract: The invention relates to an electron beam tube for displaying colour television pictures and to a method of manufacturing same, in which a graphite suspension comprising colloidal silicon oxide is used for contacting between the colour selection electrode and the patterns on the display window. This provides a method of manufacture which is simpler than the conventional methods.
Patent JP-3236586-B2 (JP)
IPC: G02F1/1337
Filed: 1999-09-24
Granted: 2001-12-10
Abstract: PROBLEM TO BE SOLVED: To provide a method for manufacturing an alignment layer having an excellent liquid crystal alignment characteristic with a smaller photoirradiation quantity in the method for manufacturing the liquid crystal alignment layer using a photoalignment treatment method. SOLUTION: The method for manufacturing a substrate with the liquid crystal alignment layer has a stage for applying a solution containing an alignment layer material having a photosensitive group to a substrate surface and a baking stage of executing the photoalignment treatment to align the alignment layer material molecules in a specific direction by irradiating the unbaked coating film with polarized UV rays and baking and curing the coating film after the photoalignment treatment.
Patent JP-3667572-B2 (JP)
IPC: B65D83/44
Filed: 1999-10-05
Granted: 2005-07-06
Abstract: <P>PROBLEM TO BE SOLVED: To provide an aerosol dispenser which possesses a container for holding a product, bears internal vacuum, and suppresses manufacturing cost.  <P>SOLUTION: While possessing the container of a ball shape, the container has an opening to which a distribution valve is attached, and the container manufactures the aerosol dispenser made from thermoplastics of higher temperatures than about 80°C in the transition temperature of glass.  <P>COPYRIGHT: (C)2005,JPO&NCIPI
Patent JP-2575355-B2 (JP)
IPC: H01M50/426
Filed: 1985-12-18
Granted: 1997-01-22
Abstract: @ The invention provides microporous polymer films which comprise a halopolymer in which the repeat units are - (C<sub>n</sub> H<sub>2n</sub>)- and -(C<sub>m</sub> X<sub>2m</sub>)-, where each X independently represents fluorine or chlorine and the values of n and m are more than one and less than six. The films of the invention can be suitable for use in high temperature applications and can be substantially inert to certain chemically agressive substances such as alkali and alkaline earth metals. The films find particular application in electrochemical cells comprising a lithium anode and thionyl chloride electrolyte.
Patent JP-3949828-B2 (JP)
IPC: G10L21/007
Filed: 1998-10-15
Granted: 2007-07-25
Abstract: PROBLEM TO BE SOLVED: To convert a voice without imparing a natural property of the voice. SOLUTION: An input sound signal Sv corresponding to a voice of a singer whose vocal mimicry is carried out is analyzed to extract a sine wave component and a residual component Rme(f). The sine wave component is voice- converting-processed based on a sine wave component of a target sound signal (sound signal of a miming object). The residual component Rme(f) is voice- converting-processed based on a residual component of the target sound signal, and a pitch component and a harmonic are added to a resultant residual component therein by a comb-shaped filter processing part 41. A converted sound signal is provided by conducting inverse FFT(fast Fourier transform) transformation in an inverse FFT processing part 28, after an attribute-converted sine wave component SINnew' and a filter-processed residual component Rnew'(f) are synthesized.
Patent JP-3723592-B2 (JP)
IPC: C01D3/16
Filed: 1994-12-16
Granted: 2005-12-07
Abstract: Process and plant for the purification of an aqueous alkali metal chloride solution containing iodide ions, according to which the iodide ions are oxidised to iodine by means of active chlorine generated in situ by electrolysis (4) of the solution and the iodine is removed over a basic halogenated anion exchange resin (5). <IMAGE>
Patent JP-3891618-B2 (JP)
IPC: F42C9/00
Filed: 1996-11-25
Granted: 2007-03-14
Abstract: The disaggregation time determination involves performing a calculation based on an impact distance, RT, to a target determined from sensor data, a projectile velocity, Vm, at a muzzle and a given disaggregation distance, Dz. The disaggregation distance is kept constant by a correction of a disaggregation time using the equation: Tz(Vm) = Tz + K*(Vm-Vov) Tz(Vm) is the corrected disaggregation time. K is a correction factor. Vov is a lead velocity of a projectile. The correction factor is calculated based upon flying time of the projectile, air resistance and a value relating to a position of the gun barrel.
Patent JP-4743670-B2 (JP)
IPC: C07C2/66
Filed: 1999-11-10
Granted: 2011-08-10
Abstract: Ethylbenzene is produced by alkylation over a split load of monoclinic silicalite alkylation catalysts having different silica/alumina ratios. A feedstock containing benzene and ethylene is applied to a multi-stage alkylation reaction zone having a plurality of series-connected catalyst beds. At least one catalyst bed contains a first monoclinic silicalite catalyst having a silica/alumina ratio of at least 275. At least one other catalyst bed contains a second monoclinic silicalite catalyst having a silica/alumina ratio of less than about 275. The alkylation reaction zone is operated at temperature and pressure conditions in which the benzene is in a gaseous phase to cause gas-phase alkylation of the aromatic substrate in the presence of the monoclinic silicalite catalysts to produce an alkylation product. The alkylation product is then withdrawn from the reaction zone for separation and recovery. The use of the split load of catalyst allows a higher purity ethylbenzene product to be produced at improved efficiencies than if only one of the catalysts were used by itself.